Analystreport

Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) had its price target raised by analysts at Maxim Group from $9.00 to $20.00. They now have a "buy" rating on the stock.

Brainstorm Cell Therapeutics Inc.  (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com